mazindol has been researched along with Diseases in Twins in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Diseases in Twins: Disorders affecting TWINS, one or both, at any age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was performed in a pair of 7 1/2 year-old monozygotic twins, with Duchenne muscular dystrophy (DMD)." | 5.06 | Treatment of Duchenne muscular dystrophy with growth hormone inhibitors. ( Betti, RT; Frota-Pessoa, O; Zatz, M, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zatz, M | 1 |
| Betti, RT | 1 |
| Frota-Pessoa, O | 1 |
1 trial available for mazindol and Diseases in Twins
| Article | Year |
|---|---|
Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.
Topics: Body Height; Body Weight; Child; Clinical Trials as Topic; Diseases in Twins; Double-Blind Method; G | 1986 |